Serum Collection Study for Assay Development
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation.
Study details:
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation. Participants will receive a dose of Gamma-PN and serum will be collected pre dose and Day 28.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
- good general health
Exclusion criteria
- no previous pneumococcal vaccine
Eligibility
Age eligible for study : NA
Healthy volunteers accepted : No
Gender eligible for study: ALL
Things to know
Study dates
Study start:
Primary completion:
Study completion finish:
Study type
DIAGNOSTIC
Phase
- PHASE1
Study ID
NCT07205289
Intervention or treatment
BIOLOGICAL: Gamma-PN
Conditions
- Pneumococcal Disease, Invasive
- Pneumococcal Disease
You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.
Research sites nearby
Closest Location:
University of Adelaide Clinical Research Facility
Select from list below to view details:
University of Adelaide Clinical Research Facility
Adelaide, South Australia, Australia
Loading map...
Who is running the clinical trial?
GPN Vaccines
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
| Participant Group/Arm | Intervention/Treatment |
|---|---|
EXPERIMENTAL: Gamma -PN
| Biological: Gamma-PN |
What is the study measuring?
Primary Outcome
| Measure | Description | Time Frame |
|---|---|---|
| OPA | Opsonophagocytic assay | 6 months |
Secondary Outcome
References
Clinical Trials Gov: Serum Collection Study for Assay DevelopmentOther trials to consider
Loading suggested trials...
